Učitavanje...
Research Progress in Non-small Cell Lung Cancer with Concomitant EML4-ALK Fusion Gene and EGFR Gene Mutation
Lung cancer is one of the most prevalence malignances, of which non-small cell lung cancer (NSCLC) account for 80%-85% of lung cancer. Molecular target therapy is one of the most popular and promising field of NSCLC treatment, and its hotspots includes EGFR (epidermal growth factor receptor), EML4-A...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Chinês |
| Izdano: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2011-11-01
|
| Serija: | Chinese Journal of Lung Cancer |
| Teme: | |
| Online pristup: | http://dx.doi.org/10.3779/j.issn.1009-3419.2011.11.09 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|